Literature DB >> 23910743

Acceptance and Commitment Therapy for drug abuse in incarcerated women.

Patricia Villagrá Lanza1, Ana González Menéndez.   

Abstract

BACKGROUND: Acceptance and Commitment Therapy is the third wave therapy with the greatest empirical evidence in the treatment of drug abuse.
METHOD: Thirty-one women with substance use disorder (SUD) were randomly assigned to two conditions, an intervention based on Acceptance and Commitment Therapy (ACT) and a control group on a waiting list. All participants were assessed three times (before treatment, at the end, and at a six-month follow-up) using urinalysis, the Mini International Neuropsychiatric Interview (MINI), the Addiction Severity Index (ASI-6), the Anxiety Sensitivity Index, and the Acceptance and Action Questionnaire (AAQ-II).
RESULTS: After 16 ACT intervention sessions, abstinence rates of 27.8% were observed, increasing to 43.8% after six months. The treatment also promoted improvements in other areas, such as reductions in the percentage of comorbid psychopathology and anxiety sensitivity, and the increase of psychological flexibility, which, in general, were not documented in the comparison group.
CONCLUSIONS: Clinical gains were achieved, and we consider ACT to be an effective and appropriate treatment to be applied in the prison context.

Entities:  

Mesh:

Year:  2013        PMID: 23910743     DOI: 10.7334/psicothema2012.292

Source DB:  PubMed          Journal:  Psicothema        ISSN: 0214-9915


  8 in total

1.  Modifiable risk factors for external cause mortality after release from prison: a nested case-control study.

Authors:  M J Spittal; S Forsyth; R Borschmann; J T Young; S A Kinner
Journal:  Epidemiol Psychiatr Sci       Date:  2017-09-25       Impact factor: 6.892

Review 2.  A systematic review of randomized controlled trials of interventions to improve the health of persons during imprisonment and in the year after release.

Authors:  Fiona G Kouyoumdjian; Kathryn E McIsaac; Jessica Liauw; Samantha Green; Fareen Karachiwalla; Winnie Siu; Kaite Burkholder; Ingrid Binswanger; Lori Kiefer; Stuart A Kinner; Mo Korchinski; Flora I Matheson; Pam Young; Stephen W Hwang
Journal:  Am J Public Health       Date:  2015-02-25       Impact factor: 9.308

3.  The Moderating Role of Experiential Avoidance in the Relationship between Posttraumatic Stress Disorder Symptom Severity and Cannabis Dependence.

Authors:  Michael J Bordieri; Matthew T Tull; Michael J McDermott; Kim L Gratz
Journal:  J Contextual Behav Sci       Date:  2014-10-01

Review 4.  The Use of Acceptance and Commitment Therapy in Substance Use Disorders: A Review of Literature.

Authors:  Joy Osaji; Chiedozie Ojimba; Saeed Ahmed
Journal:  J Clin Med Res       Date:  2020-09-21

5.  Interventions for female drug-using offenders.

Authors:  Amanda E Perry; Marrissa Martyn-St James; Lucy Burns; Catherine Hewitt; Julie M Glanville; Anne Aboaja; Pratish Thakkar; Keshava Murthy Santosh Kumar; Caroline Pearson; Kath Wright
Journal:  Cochrane Database Syst Rev       Date:  2019-12-13

Review 6.  Interventions for drug-using offenders with co-occurring mental health problems.

Authors:  Amanda E Perry; Marrissa Martyn-St James; Lucy Burns; Catherine Hewitt; Julie M Glanville; Anne Aboaja; Pratish Thakkar; Keshava Murthy Santosh Kumar; Caroline Pearson; Kath Wright; Shilpi Swami
Journal:  Cochrane Database Syst Rev       Date:  2019-10-07

7.  Interventions for drug-using offenders with co-occurring mental health problems: a systematic review and economic appraisal.

Authors:  Rebecca Woodhouse; Matthew Neilson; Marrissa Martyn-St James; Julie Glanville; Catherine Hewitt; Amanda E Perry
Journal:  Health Justice       Date:  2016-09-13

Review 8.  Are Non-Pharmacological Interventions Effective in Reducing Drug Use and Criminality? A Systematic and Meta-Analytical Review with an Economic Appraisal of These Interventions.

Authors:  Amanda E Perry; Rebecca Woodhouse; Matthew Neilson; Marrissa Martyn St James; Julie Glanville; Catherine Hewitt; Dominic Trépel
Journal:  Int J Environ Res Public Health       Date:  2016-09-29       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.